263 related articles for article (PubMed ID: 22385797)
1. Effect of smoking on oxygen delivery and outcome in patients treated with radiotherapy for head and neck squamous cell carcinoma--a prospective study.
Hoff CM; Grau C; Overgaard J
Radiother Oncol; 2012 Apr; 103(1):38-44. PubMed ID: 22385797
[TBL] [Abstract][Full Text] [Related]
2. Does transfusion improve the outcome for HNSCC patients treated with radiotherapy? - results from the randomized DAHANCA 5 and 7 trials.
Hoff CM; Lassen P; Eriksen JG; Hansen HS; Specht L; Overgaard M; Grau C; Johansen J; Bentzen J; Andersen L; Evensen JF; Overgaard J
Acta Oncol; 2011 Oct; 50(7):1006-14. PubMed ID: 21790306
[TBL] [Abstract][Full Text] [Related]
3. Effect of carboxyhemoglobin on tumor oxygen unloading capacity in patients with squamous cell carcinoma of the head and neck.
Overgaard J; Nielsen JE; Grau C
Int J Radiat Oncol Biol Phys; 1992; 22(3):407-10. PubMed ID: 1735669
[TBL] [Abstract][Full Text] [Related]
4. Tumor hypoxia is independent of hemoglobin and prognostic for loco-regional tumor control after primary radiotherapy in advanced head and neck cancer.
Nordsmark M; Overgaard J
Acta Oncol; 2004; 43(4):396-403. PubMed ID: 15303502
[TBL] [Abstract][Full Text] [Related]
5. Importance of hemoglobin concentration and its modification for the outcome of head and neck cancer patients treated with radiotherapy.
Hoff CM
Acta Oncol; 2012 Apr; 51(4):419-32. PubMed ID: 22313317
[TBL] [Abstract][Full Text] [Related]
6. DAHANCA 10 - Effect of darbepoetin alfa and radiotherapy in the treatment of squamous cell carcinoma of the head and neck. A multicenter, open-label, randomized, phase 3 trial by the Danish head and neck cancer group.
Overgaard J; Hoff CM; Hansen HS; Specht L; Overgaard M; Lassen P; Andersen E; Johansen J; Andersen LJ; Evensen JF; Alsner J; Grau C
Radiother Oncol; 2018 Apr; 127(1):12-19. PubMed ID: 29523409
[TBL] [Abstract][Full Text] [Related]
7. Combination of p16 levels and pre-radiotherapy factors predicts outcome in patients treated for oropharyngeal carcinoma.
Bar-Ad V; Wang ZX; Leiby B; Tuluc M
J BUON; 2013; 18(4):982-8. PubMed ID: 24344027
[TBL] [Abstract][Full Text] [Related]
8. Potential doubling time in head and neck tumors treated by primary radiotherapy: preliminary evidence for a prognostic significance in local control.
Corvò R; Giaretti W; Sanguineti G; Geido E; Orecchia R; Barra S; Margarino G; Bacigalupo A; Vitale V
Int J Radiat Oncol Biol Phys; 1993 Dec; 27(5):1165-72. PubMed ID: 8262843
[TBL] [Abstract][Full Text] [Related]
9. Radiation treatment interruptions greater than one week and low hemoglobin levels (12 g/dL) are predictors of local regional failure after definitive concurrent chemotherapy and intensity-modulated radiation therapy for squamous cell carcinoma of the head and neck.
McCloskey SA; Jaggernauth W; Rigual NR; Hicks WL; Popat SR; Sullivan M; Mashtare TL; Khan MK; Loree TR; Singh AK
Am J Clin Oncol; 2009 Dec; 32(6):587-91. PubMed ID: 19581794
[TBL] [Abstract][Full Text] [Related]
10. Oxygen-modifying treatment with ARCON reduces the prognostic significance of hemoglobin in squamous cell carcinoma of the head and neck.
Hoogsteen IJ; Pop LA; Marres HA; Merkx MA; van den Hoogen FJ; van der Kogel AJ; Kaanders JH
Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):83-9. PubMed ID: 16213107
[TBL] [Abstract][Full Text] [Related]
11. The effect of anaemia on efficacy and normal tissue toxicity following radiotherapy for locally advanced squamous cell carcinoma of the head and neck.
Daly T; Poulsen MG; Denham JW; Peters LJ; Lamb DS; Krawitz H; Hamilton C; Keller J; Tripcony L; Walker Q
Radiother Oncol; 2003 Aug; 68(2):113-22. PubMed ID: 12972305
[TBL] [Abstract][Full Text] [Related]
12. TP53 mutation is related to poor prognosis after radiotherapy, but not surgery, in squamous cell carcinoma of the head and neck.
Alsner J; Sørensen SB; Overgaard J
Radiother Oncol; 2001 May; 59(2):179-85. PubMed ID: 11325447
[TBL] [Abstract][Full Text] [Related]
13. Anemia is associated with lower local-regional control and survival after radiation therapy for head and neck cancer: a prospective study.
Dubray B; Mosseri V; Brunin F; Jaulerry C; Poncet P; Rodriguez J; Brugère J; Point D; Giraud P; Cosset JM
Radiology; 1996 Nov; 201(2):553-8. PubMed ID: 8888257
[TBL] [Abstract][Full Text] [Related]
14. Hypoxic modification of radiotherapy in squamous cell carcinoma of the head and neck--a systematic review and meta-analysis.
Overgaard J
Radiother Oncol; 2011 Jul; 100(1):22-32. PubMed ID: 21511351
[TBL] [Abstract][Full Text] [Related]
15. A confirmatory prognostic study on oxygenation status and loco-regional control in advanced head and neck squamous cell carcinoma treated by radiation therapy.
Nordsmark M; Overgaard J
Radiother Oncol; 2000 Oct; 57(1):39-43. PubMed ID: 11033187
[TBL] [Abstract][Full Text] [Related]
16. Synchronous and metachronous head and neck carcinomas.
Schwartz LH; Ozsahin M; Zhang GN; Touboul E; De Vataire F; Andolenko P; Lacau-Saint-Guily J; Laugier A; Schlienger M
Cancer; 1994 Oct; 74(7):1933-8. PubMed ID: 8082099
[TBL] [Abstract][Full Text] [Related]
17. Locally advanced head and neck cancer treated with accelerated radiotherapy, the hypoxic modifier nimorazole and weekly cisplatin. Results from the DAHANCA 18 phase II study.
Bentzen J; Toustrup K; Eriksen JG; Primdahl H; Andersen LJ; Overgaard J
Acta Oncol; 2015 Jul; 54(7):1001-7. PubMed ID: 25629651
[TBL] [Abstract][Full Text] [Related]
18. Locally advanced stage IV squamous cell carcinoma of the head and neck: impact of pre-radiotherapy hemoglobin level and interruptions during radiotherapy.
Rades D; Stoehr M; Kazic N; Hakim SG; Walz A; Schild SE; Dunst J
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1108-14. PubMed ID: 17905528
[TBL] [Abstract][Full Text] [Related]
19. Pretreatment anemia is correlated with the reduced effectiveness of radiation and concurrent chemotherapy in advanced head and neck cancer.
Prosnitz RG; Yao B; Farrell CL; Clough R; Brizel DM
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1087-95. PubMed ID: 15752888
[TBL] [Abstract][Full Text] [Related]
20. Prognostic impact of total tumor volume and hemoglobin concentration on the outcome of patients with advanced head and neck cancer after concomitant boost radiochemotherapy.
Rudat V; Dietz A; Schramm O; Conradt C; Maier H; Flentje M; Wannenmacher M
Radiother Oncol; 1999 Nov; 53(2):119-25. PubMed ID: 10665788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
